Evaluate Self-Injury Treatment and Unwanted Effects

To evaluate a self injury treatment package and unwanted effects, define Hugo's active components, assessment link, exposure, plan integrity, self-injury and injury measures, communication, quality of life, collateral behavior, restrictions, and person-family experience. Use a design able to support the intended conclusion. Review benefits and harms by phase and setting, then apply predeclared continuation, revision, pause, and escalation rules.

Define Hugo's treatment question

State the functional or clinical hypothesis, target outcome, person-selected priority, active components, comparison, phase-change rule, risk boundary, and conclusion the design may support.

Measure exposure and integrity

Report eligible sessions or opportunities, actual component delivery, communication access, partner response, prompts, protective procedures, missing data, and deviations. An intervention cannot be judged from calendar time alone.

Track multiple outcomes

Include event frequency or occurrence, episode and contact measures when relevant, injury and health routes, communication, engagement, participation, distress, choice, relationships, sleep or other authorized health context, and quality of life.

Look for unwanted effects

Monitor new topographies, avoidance, distress, dependence, prompt escalation, response bursts, communication loss, restricted access, reduced participation, caregiver burden, staff injury, protective-equipment effects, and treatment drift.

Use explicit decision rules

Predeclare what supports continuation, revision, component analysis, added health or interdisciplinary review, pause, urgent escalation, generalization testing, fading, or discontinuation. Record uncertainty alongside the decision.

Build Hugo's self-injury treatment-package evaluation

Create one versioned record for the outpatient clinic and home. Include Hugo's event and episode definitions, exposure, observed effects, person report, health and crisis routes, communication and AAC, context, assessment evidence, safeguards, treatment components, role authority, integrity, restrictions, raw outcomes, missingness, unwanted effects, experience, bounded decision, and reassessment trigger. Store urgent information for authorized rapid access and other sensitive data with role limits. Keep a treatment-version table with components added, removed, or changed; rationale; setting; exposure; integrity; response measures; injury and health outcomes; restrictions; person feedback; unwanted effects; and decision.

Validate Hugo's evidence

Reproduce three ten-session versions, self-injury occurrence of 7/10, 4/10, and 3/10, communication of 2/10, 6/10, and 7/10, two new avoidance sessions, and one missed partner response.

Connect Hugo's evidence to an action

The clinician examines the design and component history, repairs the missed response, and assesses the new avoidance pattern with Hugo and family before continuation. Medical or safety concerns follow their separate routes.

Work through Hugo's example

The team reviews 30 eligible sessions across three plan versions of ten sessions each. Self-injury occurs in 7 of 10, 4 of 10, and 3 of 10 sessions. Communication occurs in 2 of 10, 6 of 10, and 7 of 10. The third version also has two sessions with a new avoidance pattern and one missed partner response. Preserve each planned and eligible unit, event, episode and contact when relevant, communication access, partner response, health or crisis route, support version, restriction, invalid record, correction, and outcome. This fictional example demonstrates one workflow control. It supplies no diagnosis, intent finding, function proof, medical clearance, restraint permission, treatment effect, coverage result, or safety guarantee for Hugo.

Address Hugo's main interpretation risk

The phased pattern is consistent with change, yet time, practice, setting, component bundles, and measurement could explain part of it. Lower session-level occurrence does not show injury reduction, quality-of-life improvement, or which component produced change. Review exposure, topography, body site, observed effect, report, health, pain, sleep, medication, communication, antecedent, consequence, setting, support delivery, restrictions, person priorities, missingness, and design strength separately. Calm appearance, compliance, blocked contact, zero events, or staff confidence cannot establish wellbeing, assent, safety, function, or effectiveness.

Set Hugo's clinical scope

For Hugo's self-injury treatment-package evaluation, the CASP public summary supplies high-level ABA behavioral-health-treatment scope for autistic people. The current BACB Ethics Code addresses competence, client involvement, consent and assent when applicable, medical needs, assessment, intervention, risk, data, documentation, confidentiality, and evaluation for covered people. The BACB outline is examination content. These sources require qualified clinical judgment and create no medical, psychiatric, emergency, restraint, facility, legal, or payer authority.

Use multidisciplinary assessment for Hugo

The UK NICE NG11 recommendations distinguish self-injury from intentional self-harm, include both in risk review, and call for person-centered assessment of communication, physical and mental health, medication effects, pain or distress, environment, history, direct observation, quality of life, and changing function. NICE supplies useful assessment questions for Hugo; it is UK guidance for people with learning disabilities whose behavior challenges and does not control U.S. practice.

Read the self-injury safety review narrowly for Hugo

A 2024 scoping review of protective procedures in functional analyses of self-injury screened studies from 2009 through 2022 and included 187 studies. At least one protective procedure appeared in 130 studies, or 69.52%, and 83 studies, or 44.39%, explicitly linked protections to safety. Reporting varied, and injury reporting was sparse. The review describes categories such as environmental safety, protective equipment, staffing, session parameters, and mechanical restraint. It supplies no permission or universal protocol for Hugo.

Scope treatment evidence for Hugo

The 2001 through 2016 treatment review updates earlier behavioral-treatment literature for people with intellectual and developmental disabilities. Its abstract reports strong reductions in many reviewed applications, especially assessment-informed treatment, while noting increased automatically maintained self-injury and lower efficacy than the earlier review. Published single-case results support individualized evaluation for Hugo; they do not guarantee a result, identify a function from topography, or replace current licensed and payer requirements.

Keep risk evidence individualized for Hugo

A systematic review of developmental and persistence risk examined longitudinal, prospective, and retrospective studies through January 2022. The authors found major methodological limitations and an undeveloped population-level risk model. They also reject an either biological or behavioral split. For Hugo, health, biology, learning history, communication, context, and person report can all remain active questions; correlates never determine one person's cause or future course.

Protect communication and urgent routes for Hugo

ASHA's AAC portal says AAC users should always have access to their communication tools or devices. Hugo's primary and agreed backup communication remain available during health review, assessment, support, distress, and emergencies. For danger or a medical emergency in the United States, SAMHSA directs people to call 911 or go to the nearest emergency room. SAMHSA's current 988 FAQ identifies 988 as support for suicide, mental-health, and substance-use crises. These routes serve different needs, and routine ABA review never delays urgent action.

Choose Hugo's next bounded action

Review after worsening self-injury or injury, new behavior, loss of communication, integrity decline, setting change, unwanted effect, increased restriction, person or family concern, weak generalization, or missed decision threshold. Record the qualified owner, source, effective date, plan version, urgent route, access arrangement, authority, implementation check, accessible explanation, disagreement or complaint path, and reassessment trigger. Preserve earlier evidence when conditions change.

Close Hugo's playbook

Review the self-injury treatment-package evaluation with Hugo, the qualified behavior analyst, family or authorized decision-maker when applicable, direct team, and specialists named in the manifest. Confirm that emergency response, health care, psychiatric care, behavioral assessment, communication, safeguards, treatment, and restriction review remain separate; every denominator is reproducible; AAC, basic needs, prescribed care, valid refusal, and emergency help remain protected; urgent needs received action; each restrictive measure has authority and review; and every conclusion stays bounded to sampled conditions. Keep this page draft and noindex until every required review is complete.

How to Evaluate a Self-Injury Treatment Package and Unwanted Effects